When Orbis' Danny Haddad visited Ethiopia in 1996, he found a lagging eye health industry and an alarming number of trachoma cases. The sight-saving NGO has spent the past 20 years treating infectious blindness and building a pool of eye health experts in the country.
Within three decades, India has turned itself into a model for good, affordable eye care. Here's how.
As a two-decade push to end blindness by 2020 draws to a close, advocates indicate the goal is unlikely to be met. In hindsight, they admit they could have framed the goal better. Going forward, bold action is needed.
In a conversation with Devex, Essilor's Jayanth Bhuvaraghan explains why poor vision isn't getting the attention it needs and how action around this unaddressed disability can improve lives and economies.
Tea pickers in India are at the center of a new study demonstrating the outsized impact that improved eyesight can have on productivity and income. The results of a randomized controlled trial surpass the productivity increases reported by every other health intervention in low- and middle-income countries studied in scientific literature trials.
Ghana has become the first country in sub-Saharan Africa to eliminate trachoma, WHO announced Wednesday, as pharmaceutical company Pfizer said it would top up its donations of a crucial antibiotic.
The Commonwealth Heads of Government Meeting 2018 launched Monday under the theme "Towards a Common Future," as government officials, academics, and development professionals arrived in London with a laundry list of concerns ranging from Brexit to LGBTQ rights to climate change.
Vision for a Nation Foundation — a 2018 Bond Innovation Award Winner — explains how it has worked with Rwanda's Ministry of Health to transform eye care in Rwanda.
As the world health community faces potential funding cuts to efforts to tackle the world's deadliest diseases, Devex takes a look at lessons learned from three watershed disease eradication efforts.
A new joint fund puts river blindness and lymphatic filariasis on the docket for the next diseases the would could eliminate. The Carter Center's director for river blindness, lymphatic filariasis, schistosomiasis, and malaria programs told Devex what a successful intervention could look like, and how it could be a treatment game changer.
Abu Dhabi's crown prince and the Bill & Melinda Gates Foundation today launched a new $100 million Reaching the Last Mile Fund to eradicate river blindness and lymphatic filariasis in key countries in the Middle East and Africa.
Peter Sands, the new executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, wants his organization to be more technologically savvy and learn more from its past experiences, and do so quickly. Devex spoke with Sands Tuesday after the Global Fund board announced his surprise election to one of the most high-profile jobs in global development.
Some of the more readily treatable or preventable causes of blindness are often forgotten in health care provision. Two new financing mechanisms aim to see if private capital and creativity can make a difference.
New data published on World Sight Day reveals that progress on ending the leading cause of blindness in developing countries has been at a near standstill since 1990. The rate of blindness is set to double by 2030, affecting women disproportionately.
Inter-sectoral collaborations and partnerships, including the engagement of community health workers and leaders, were key in the elimination of trachoma in Laos and Cambodia, says a WHO official.